Ausgabe 2/2016
Inhalt (11 Artikel)
NON-THEMATIC REVIEW
The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma
Yunfei Liao, Yong Feng, Jacson Shen, Francis J. Hornicek, Zhenfeng Duan
Open Access
Non-Thematic Review
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
Christophe Y. Calvet, Lluis M. Mir
NON-THEMATIC REVIEW
Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology
Raghuveera Kumar Goel, Kiven Erique Lukong
NON-THEMATIC REVIEW
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer
Wenli Liu, Griffin P. Rodgers
NON-THEMATIC REVIEW
Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis
Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn
NON-THEMATIC REVIEW
Deciphering the function of non-coding RNAs in prostate cancer
João Ramalho-Carvalho, Bastian Fromm, Rui Henrique, Carmen Jerónimo
CLINICAL
Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design
Jason K. Sicklick, Paul T. Fanta, Kelly Shimabukuro, Razelle Kurzrock
Clinical
Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?
Cyrus Chargari, Karyn A. Goodman, Ibrahima Diallo, Jean-Baptiste Guy, Chloe Rancoule, Jean-Marc Cosset, Eric Deutsch, Nicolas Magne
Clinical
miR clusters target cellular functional complexes by defining their degree of regulatory freedom
Jörg Haier, Anda Ströse, Christiane Matuszcak, Richard Hummel
Clinical
Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases
Minetta C. Liu, Javier Cortés, Joyce O’Shaughnessy
Clinical
Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management
Kosei Nakajima, Dong Hyo Kho, Takashi Yanagawa, Melissa Zimel, Elisabeth Heath, Victor Hogan, Avraham Raz